U.S. Markets open in 9 hrs 29 mins

CANAQUEST MEDICAL CORP is the Winner of the Go Global Awards "Business of the Year – Category of Life Science” presented by the International Trade Council

Research & development is a primary focus for this medical cannabis company 

TORONTO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the "Company" or “CanaQuest”) announces that it has won the Go Global Awards "Business of the Year – Category of Life Science”, presented by the International Trade Council.

The final judging took place during the Think Global Conference on October 22nd and 23rd in Chicago. This recognition will further open doors for international business opportunities. CanaQuest presented before a select judging panel and an audience of CEOs, investors and Government Ministers and Ambassadors. To view the presentation provided, visit http://nnw.fm/Go-Global-Awards-Presentation.

Recently, CanaQuest was granted a cannabis sales-import-export license from Health Canada. Additionally, CanaQuest filed an international patent on its first game-changing formulation, Mentabinol™, which protects THC users from negative psychotic side effects.

The Company is focused on the development of proprietary research and products utilizing cannabis oil combined with other botanical extracts, including algae oil. Positive data from CanaQuest’s research and pre-clinical trials has positioned the Company to bring its first CBD and THC based products to market.

The Company has engaged two prestigious Canadian universities, Western University and the University of Waterloo, to provide research and to create these unique formulations and products. Our research is focused on mitigation of the spread of cancerous tumors and the development of novel pharmacotherapies for mental health.

The company has found a competitive advantage working with Dr. Steve Laviolette, a scientific veteran with over 13 years of research experience in the field of mental health and cannabis, and his dedicated scientific team of 12 scientists at Western University. This partnership gives our Company a tremendous competitive advantage compared to sporadic publicly disclosed research in this area. The completed pre-clinical trials at the Western University lab have demonstrated exciting results.

“We continue to be enthusiastic about our partnership with CanaQuest, and we are proud they are winners of the Go Global Awards “Business of the Year – Category of Life Science,” states Dr. Steven Laviolette. “The results of our research have demonstrated safer and clinically superior cannabinoid formulations aimed at treating the symptoms of various mental disorders.”

Paul Ramsay, Co-Founder and President of CanaQuest, adds, “Being a winner of the Go Global Awards Business of the Year – category of Life Science, out of over 3,000 applications, is an honor and speaks highly of the tremendous accomplishments by Dr. Steven Laviolette and his team.”
                   

About CanaQuest Medical Corp

CanaQuest Medical Corp is a life science company focused on medical cannabis products. The Company is committed to developing novel health products that utilize cannabis, hemp, and botanical extracts, including algae oils. The Company has engaged two prestigious Canadian universities to research and develop formulated products, which the company is in the process of launching. Our research is focused on the use of cannabis in the context of cancer and the use of cannabis derivatives for the development of our novel pharmacotherapies for mental health, such as anxiety, depression, addiction, schizophrenia, and Post Traumatic Stress Disorder “PTSD”. CanaQuest was awarded a cannabis sales-import-export license from Health Canada. Additionally, CanaQuest filed an international patent on a first game changing discovery, Mentabinol™, protecting THC users from negative psychotic side effects.

For more information, visit the CanaQuest website at http://www.canaquest.com

About the International Trade Council

The International Trade Council Go Global Awards bring together hundreds of senior executives from some of the world's most innovative manufacturers, re-manufacturers and exporters, along with representatives from government bodies, trade associations, venture capital firms and financial institutions. The awards help celebrate the companies that are driving the economy forward through their innovations, technologies and strategies. While the Go Global Awards offer the opportunity to be recognized and honored by their peers it also goes beyond winning trophies and citations. The program aims to build a community of manufacturers, exporters and related service providers to support one another, share ideas, create partnerships and build on their existing knowledge and connections. Winners gain access to unique international platforms for their projects and companies throughout the extensive International Trade Council network of more than 76 countries and over 418 professional organizations worldwide.

For more information, visit the International Trade Council website at https://www.tradecouncil.org

FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking statements" as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.

Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

COMPANY CONTACT:
Paul Ramsay
Co-Founder & President
CanaQuest Medical Corp
paul@canaquest.com : Tel.: 416-704-3040